Self-testing is paving way for novel ways to diagnose, monitor, and address patients and their treatment. Companies are developing these testing kits along a continuum of prevention and wellness strategies, ranging from acute infection diagnoses and chronic disorder management to detecting potential risks of ailments.
In its recent report, Future Market Insights (FMI) opines that global sales of self-testing kits market will be worth USD 11 billion by 2030 . The COVID-19 crisis has further fueled adoption of self-testing kits as consumers are strictly following physical distancing protocol and healthcare facilities are avoiding in-person patient visits.
Growing Abuse of Prescription Drugs to Offer
Testing for drugs of abuse in medical practice is making rapid inroads into pain management domain, primarily owing to rising usage of opioids to treat chronic issues as well as morbidity and mortality associated with misuse of these drugs.
A survey by American Addiction Centers finds that non-medical consumption and abuse of prescription drugs is among major health concerns in the US. Abuse of prescribed opioid pain relievers results in more mortalities every year compared to all illegal drugs combined.
Although adoption of self-testing kits in drug of abuse testing is capturing meagre share in global market, revenues are likely to soar at around 8% CAGR in the next decade.
The Online Channel
Pharmacies have hit the internet and received positive response. Consumers are rapidly adapting to purchasing self-testing kits online against conventional approach of purchasing them from retail pharmacy stores after seeking medical advice.
Furthermore, the COVID-19 pandemic and subsequent ripple effects have compelled retailers to close their stores, hitting profit margins of self-testing kit manufacturers. With brick-and-mortar stores shutting down, market players are placing their bets on online platforms to survive pandemic shockwaves.
Online pharmacies are likely to emerge as a lucrative channel in the future, equating to nearly USD 3 billion in revenues by 2030-end.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
North America Self-testing Market
About 30% of global self-testing market revenue will come from North America, with US accounting for the major share. According to a report by Centers for Disease Control (CDC), cases of diabetes in the US have increased to around 34.2 million.
The report further states that over a third of adult population in the country suffer from prediabetes – about 84 million people, or 33.9% of the entire US population.
The US government has been focusing on HIV efforts over past few decades and is leading donor to international HIV efforts worldwide. In addition, the administration has established PEPFAR – US global effort to battle HIV.
Furthermore, reagent shortages, testing backlogs, and restricted access are contributing to inadequate COVID-19 testing in North America. As a response, the US Food and Drug Administration (FDA) is granting rapid approvals to COVID-19 self-testing kits.
Request a sample specific to North America market
Europe Self-testing Market
Europe self-testing market is majorly driven by high prevalence of diabetes. FMI finds that prevalence rate of diabetes in countries such as Portugal, Switzerland, and Austria was 9.8%, 5.7% and 6.8% in 2019 respectively.
Moving ahead, a large-scale population survey has revealed that home self-testing with cost-effective flow diagnoses is authentic way to track COVID-19 crisis. About 105,651 individuals across the UK tested for COVID-19 antibodies with finger-prick blood test, as part of REACT (REaltime Assessment of Community Transmission), with lateral flow testing method.
Such rigorous R&D activities in COVID-19 diagnosis is working in favor of self-testing market in Europe. While Germany and the UK are spearheading the regional market, Russia and rest of Europe will reflect lucrative growth potential in near future.
Request a sample specific to Europe market
Asia Pacific Self-testing Market
While developed regions are capturing significant share in global self-testing market, markets in East and South Asia are experiencing meteoric growth. China, India and Indonesia account for almost 75% of overall HIV cases in Asia Pacific (APAC), states Avert.
Moreover, recent survey by Avert has shown that innovative pilots providing supervised HIV self-testing kits to key demographics in Thailand attracted significantly greater proportion of first-time testers compared to face-to-face HIV testing (47% compared to 18%) and counseling.
In similar fashion to North America and Europe, innovators in Asia are turning to COVID-19 self-testing kits. Singapore-based Sensing Self has designed rapid self-testing kit for COVID-19. The kit has acquired licenses from the US, India, and Europe.
Digital monitoring instruments have emerged as among the game-changers for healthcare industry, as they facilitate care for diseases ranging from chronic conditions to recovery from acute episodes of care by collecting valuable patient data at home settings.
The COVID-19 pandemic has further underscored the importance of digital monitoring instruments as policy changes amid the pandemic due to riskiness of in-person patient visits have created fertile breeding ground for their application.
Over decade ahead, digital monitoring instruments will remain the preferred product category. However, FMI highlights that adoption of test panels and dip cards will soar at greater pace in coming years.
About 8 out of 10 consumers prefer using self-testing kits for testing blood glucose, and the trend will follow positive trend through 2030. As per the International Diabetes Federation (IDF), nearly 463 million individuals (aging 20-79 years) were suffering from diabetes, and the number will rise 700 million by 2045.
On the flip side, FMI notes that adoption of self-testing kits for thyroid testing purposes will rise at double-digit CAGR over following decade. Recent estimates suggest that thyroid disorders such as hyperthyroidism, hypothyroidism, and goiter are prevalent conditions affecting over 750 million people worldwide.
Urine test is considered as the most prevalent form of drug and alcohol testing. The procedure is performed as part of pre-employment screening, particularly for employees in specific job roles. At present, urinalysis is least invasive and legally acceptable sort of drug testing.
As per FMI, urinalysis accounts for around 45% of total self-testing market value. However, the sample type will lose its share to vaginal swab and semen in near future.
Retail pharmacies have been the conventional distribution channels for self-testing kit manufacturers. By 2030, sales of self-testing kits via retail pharmacies will register revenue around US$ 3.5 Bn.
However, the retail industry is grappling with the COVID-19 impact as lockdowns and subsequent restrictions have compelled retail owners to shut down their shops. As such, players in self-testing market are rapidly turning to online pharmacies to remain afloat amid the pandemic.
FMI further reveals that online pharmacies and retail pharmacies will share nearly equal divide in global self-testing market by 2030.
The market is characterized by leading players capturing significant chunk of overall revenue. In order to maintain their competitiveness, market players are developing their offerings with blend of innovation to serve various diseases and expand their regional footprint.
The COVID-19 pandemic has raised implications of rapid and accurate testing of individuals. Players are thus, rethinking their existing pipelines to develop self-testing kits for at-home COVID-19 diagnosis.
Bio-Rad Laboratories has developed automated random access system for blood screening and blood typing as a move to enter into the US transfusion medicine industry. The offering combines design and functionality to satiate evolving needs of modern immunohematology laboratory. Moreover, it needs minimum workspace while offering maximum workflow optimization.
Thermo Fisher Scientific has developed fully automated digital microscope for effective drug examination on blood samples and body tumor cells. The automated microscope will meet rising demand for applications in cutting-edge biological research.
Abbott Laboratories has developed rapid point-of-care (POC) testing kit for detecting COVID-19 that will run on the firm’s ID NOW™ platform, delivering swift results in broad range of healthcare settings such as urgent care clinics, physicians' offices and hospital emergency departments.
Bione has recently introduced rapid COVID-19 at-home testing kit that provides accurate results within minutes, crucial in timely screening of the coronavirus.
BTNX Inc. has rolled out controls for several rapid testing such as infectious diseases, drug of abuse, and tumor markers.
In addition to these, some other key players in self-testing market include
- ACON Laboratories Inc.
- ARKRAY Inc.
- Assure Tech (Hangzhou) Co. Ltd.
- Becton, Dickinson & Company
- Bionime Corporation
- Roche Holding AG
- Quidel Corporation
- True Diagnostics Inc.
The list is only indicative – full list of self-testing market key players is available upon request.
Data Virtualization Cloud Market Report: Scope
Historical Data Available for
USD Million for value
Key Regions Covered
North America, Latin America, Europe. South Asia, East Asia, Oceania and Middle East & Africa (MEA)
Key Countries Covered
US, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, BENELUX, China, Japan, South Korea, India, ASEAN, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, Israel, South Africa
Key Segments Covered
Product Type, Application, Sample Type, Distribution Channel, and Region
Key Companies Profiled
Abbott Laboratories, ACON Laboratories Inc., BTNX Inc, ARKRAY Inc., Assure Tech (Hangzhou) Co. Ltd., Becton, Dickinson & Company, Bionime Corporation, Roche Holding AG, Quidel Corporation, True Diagnostics Inc., Bio-Rad Laboratories, and Thermo Fisher Scientific (only indicative list)
Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing
Available upon Request
Key Questions Answered by the Report
- What is the self-testing market size?
The global self-testing market size will value around US$ 6.8 Bn in 2020. The growth rate for self-testing market will be 5.5% CAGR during 2020-2030.
- Which is the largest market for self-testing?
North America represents the largest market for self-testing kits, globally, followed by Europe, owing to well-established healthcare infrastructure and supportive government policies.
- Which are the top companies in global self-testing market?
Abbott Laboratories, ACON Laboratories Inc., BTNX Inc, ARKRAY Inc., and Assure Tech (Hangzhou) Co. Ltd. are among the key players in self-testing market.
- For which application are self-testing kits available?
Companies generally offer self-testing kits for various applications including, blood glucose testing, pregnancy & fertility testing, and cancer testing, to name a few. While adoption in blood glucose testing will remain high, usage in thyroid testing will gain momentum in coming years.
- What is the outlook of East Asia self-testing market?
Self-testing kits in East Asia are witnessing huge demand, given rising trend of home diagnosis as well as surging investments in upgradation of healthcare infrastructure.
- Which distribution channel is highly lucrative for self-testing kits manufacturers?
Market players continue to reap substantial revenues from retail pharmacies. However, they are also exploring new revenue streams in online pharmacies and supermarkets/hypermarkets.
- What are the uses of self-testing kits?
Self-testing kits are beneficial for rapid and cost-effective diagnoses of several disorders without the need for medical experts.
Enquiry before Buying
- Is this research conducted by Future Market Insights?
Yes, the self-testing market research has been conducted by expert analysts of Future Market Insights through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to research analyst
- What research methodology is followed by FMI?
FMI follows a methodology that encompasses demand side assessment of the market, and triangulates the same through supply side analysis. This methodology is based on use of standard market structure, methods and definitions. Request detailed methodology
- Who are the respondents for primary research?
FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. For a full list of primary respondents, please reach out to us.
- What are the sources of secondary research?
FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
- Is a sample of this report available for evaluation?
Yes, you can request a sample and it will be sent to you through an email.
- How can I buy this report?
FMI provides a secure online payment system to buy report seamlessly. You can buy the report securely and safely.
- Digital Monitoring Instruments
- Dip Cards
- Test Panels
- Blood Glucose Testing
- Pregnancy & Fertility Testing
- Cancer Testing
- STD/ STI Testing
- Drug of Abuse Testing
- Cholesterol Testing
- HIV Testing
- Thyroid Testing
- Vaginal Swab
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
- North America (US, and Canada)
- Latin America (Brazil, and Mexico)
- Europe (Germany, UK, Russia, France, and Italy)
- South Asia (India, Indonesia, Thailand, and Malaysia)
- East Asia (China, Japan, and South Korea)
- Oceania (Australia and New Zealand)
- Middle East & Africa (MEA) (Turkey, GCC Countries, and South Africa)